METTL3 and cancer: On the contrary, in colorectal cancer, METTL3-mediated m6A modification enhances the binding of circALG1 to miR-342-5p, thereby upregulating placental growth factor (PGF) expression, which accelerates cancer cell metastasis (Lin et al., 2022b).